LFM-A-13

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameLFM-A-13
Drug Alias NameLFM-A13LFM-A-13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesParker Hughes Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParker Hughes Cancer Center
Active IndicationsN/A
Inactive IndicationsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A